{"title":"消除残余CA 19-9半衰期依赖抗原:一种更准确解释肿瘤标志物随访的创新方法","authors":"P. Oehr","doi":"10.52768/2379-1039/1967","DOIUrl":null,"url":null,"abstract":"Objectives: Tumour markers provide insights into the course of disease and response to therapy in carcinoma patients, allowing physicians to determine changes in marker levels during disease. We aimed to evaluate the value of newly produced CA 19 9 levels in determining the response to treatment and prognosi in patients with pancreatic adenocarcinoma.","PeriodicalId":90942,"journal":{"name":"Open journal of clinical & medical case reports","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up\",\"authors\":\"P. Oehr\",\"doi\":\"10.52768/2379-1039/1967\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: Tumour markers provide insights into the course of disease and response to therapy in carcinoma patients, allowing physicians to determine changes in marker levels during disease. We aimed to evaluate the value of newly produced CA 19 9 levels in determining the response to treatment and prognosi in patients with pancreatic adenocarcinoma.\",\"PeriodicalId\":90942,\"journal\":{\"name\":\"Open journal of clinical & medical case reports\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open journal of clinical & medical case reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52768/2379-1039/1967\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open journal of clinical & medical case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52768/2379-1039/1967","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up
Objectives: Tumour markers provide insights into the course of disease and response to therapy in carcinoma patients, allowing physicians to determine changes in marker levels during disease. We aimed to evaluate the value of newly produced CA 19 9 levels in determining the response to treatment and prognosi in patients with pancreatic adenocarcinoma.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
